PBS Website Update - 1 April 2021
Page last updated: 1 April 2021
The Schedule of Pharmaceutical Benefits was updated on 1 April 2021 and the Summary of Changes can be found on the New, Amended and Deleted Items page.
The following updates have also been made to the PBS Website.
- Addendum to Schedule of Pharmaceutical Benefits
- Drugs subject to Price Disclosure - 1 April 2021
- Formulary Allocations - 1 April 2021
- Ex-manufacturer price - 1 April 2021
- First New Brand Price Reductions - 1 April 2021
- Items Exempt from Statutory Price Reductions - 1 April 2021
- General Statement for Drugs for the Treatment of Hepatitis C - 1 April 2021
- Medicine Status Website - 1 April 2021
- Stage 2 PBS Process Improvements – Resubmission Pathways Webinar Recording Available - 31 March 2021
- 2021 April Cycle – Brand Price Reductions and Savings to Patients - 31 March 2021
- Agenda for the July 2021 PBAC meeting - 31 March 2021
- Cost Recovery Fees and Charges - 31 March 2021
- AMWG Streamlined Pathways Subgroup - 30 March 2021
- PBAC Stakeholder Meetings - 26 March 2021
- Post-Market Review of medicines available on the PBS Opiate Dependence Treatment Program - 24 March 2021
- Active Ingredient Prescribing - 23 March 2021
- PBAC Public Summary Documents (first time rejections and deferrals) - November 2020 meeting - 19 March 2021
- Consultation: Critical Technologies for Australia – Agriculture & Health Sectors - 19 March 2021
- Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 18 March 2021
- Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 18 March 2021
- Pharmaceutical Benefits Scheme Continued Dispensing Arrangements - 18 March 2021
- Health Products Portal Industry Webinars - 12 March 2021
- PBS Calendars - 12 March 2021
- Stage 2 PBS Process Improvements – Resubmission Pathways Webinar - 10 March 2021
- Price Disclosure Reductions for 2021 April Cycle - 2 March 2021
